Dechra Pharmaceuticals PLC — Director's Dealing 2017

Jun 22, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8577I

Dechra Pharmaceuticals PLC

22 June 2017

22 June 2017

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 21 June 2017 Ian Page, Director, sold 134,500 ordinary shares in the Company at a price of £19.27 each. 

Following this disposal Ian Page's beneficial interest in the Company is 676,808 shares (0.726% of the current issued share capital).

The Notification of Dealing Forms set out below are provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Ian Page
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Sale of Shares
c)	Price(s) and volumes(s)	Price(s) £19.27	Volume(s) 134,500
d)	Aggregated information -  Aggregate volume -   Price -   Total	15,000 at 1942p 7,500 at 1934.49p 13,000 at 1935p 7,500 at 1935.42p 7,000 at 1931.32p 3,500 at 1930.6p 27,500 at 1927.5p 14,000 at 1925p 5,000 at 1925p 12,500 at 1926.42p 20,000 at 1910p 2,000 at 1910.41p Total 134,500 1927.64p
e)	Date of the transaction	21 June 2017
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKBDNOBKKPAB